Contieri, R; Beijert, ; Martini, A; Camperat, EM; Hernandez, ; Bruins, HM; Dominguez-Escrig, JL; Liedberg, F; Masson-Lecomte, A; Cohen, D; Mostafid, H; Shariat, SF; Roupret, M; Pradere, B; Zigeuner, R; Soria, F; Soukup, ; Redorta, JP; Capoun, O; Burger, M; Gontero, P; Sylvester, R; Mertens, L; Van Rhijn, BWG.
Towards defining follow-up strategies for patients with primary (first diagnosis) EAU2021 intermediate-risk non-muscle invasive bladder cancer.
EUR UROL. 2024; 85: S1164-S1165.-39th Annual EAU Congress; APR 5-8,2024; Paris, FRANCE.
[Poster]
Web of Science